Revascularization in severe left ventricular dysfunction

Journal of the American College of Cardiology

Volumn 65, Issue 6, 2015, Pages 615-624

  Velazquez, Eric J ^a   Bonow, Robert O ^b  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

coronary artery bypass grafting; coronary artery disease; heart failure

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOSORBIDE DINITRATE; PROPRANOLOL;

BARE METAL STENT; CHRONIC DISEASE; COMORBIDITY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; DISEASE SEVERITY; DRUG DOSE TITRATION; DRUG ELUTING STENT; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE REMODELING; HIGH RISK PATIENT; HUMAN; ISCHEMIC CARDIOMYOPATHY; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MITRAL VALVE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; OBSERVATIONAL STUDY; OPTIMAL DRUG DOSE; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; QUALITY OF LIFE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; STABLE ANGINA PECTORIS; SURVIVAL RATE; DIAGNOSIS; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE FUNCTION; PATHOPHYSIOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX; SURGERY; TREATMENT OUTCOME;

ECHOCARDIOGRAPHY; HUMANS; MYOCARDIAL REVASCULARIZATION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84922880633     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.10.070     Document Type: Review

References (77)

1. A.S. Go, D. Mozaffarian, V.L. Roger American Heart Association Statistics Committee and Stroke Statistics Committee Heart disease and stroke statistics - 2014 update: a report from the American Heart Association Circulation 129 2014 e28 e292
2. T.E. Owan, D.O. Hodge, and R.M. Herges Trends in prevalence and outcome of heart failure with preserved ejection fraction N Engl J Med 355 2006 251 259
3. C.W. Yancy, M. Jessup, B. Bozkurt for the American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines 2013 ACCF/AHA Guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 62 2013 e147 e239
4. M. Gheorghiade, G. Sopko, and L. De Luca Navigating the crossroads of coronary artery disease and heart failure Circulation 114 2006 1202 1213
5. G.M. Felker, L.K. Shaw, and C.M. O'Connor A standardized definition of ischemic cardiomyopathy for use in clinical research J Am Coll Cardiol 39 2002 210 218
6. J.J. McMurray, S. Adamopoulos, S.D. Anker for the ESC Committee for Practice Guidelines ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur Heart J 33 2012 1787 1847
7. J.C. Manley, J.F. King, and H.J. Zeft The "bad" left ventricle: results of coronary surgery and effect on late survival J Thorac Cardiovasc Surg 72 1976 841 848
8. R.E. Vlietstra, J.L. Assad-Morell, and R.L. Frye Survival predictors in coronary artery disease. Medical and surgical comparisons Mayo Clin Proc 52 1977 85 90
9. S.L. Faulkner, W.S. Stoney, and W.C. Alford Ischemic cardiomyopathy: medical versus surgical treatment J Thorac Cardiovasc Surg 74 1977 77 82
10. E.L. Alderman, P. Fischer, and G.C. Litwin Results of coronary artery surgery in patients with poor left ventricular function (CASS) Circulation 68 1983 785 795
11. J.D. Pigott, N.T. Kouchoukos, and A. Oberman Late results of surgical and medical therapy for patients with coronary artery disease and depressed left ventricular function J Am Coll Cardiol 5 1985 1036 1045
12. E.P. Bounous, D.B. Mark, and B.G. Pollock Surgical survival benefits for coronary disease patients with left ventricular dysfunction Circulation 78 1988 I151 I157
13. C.M. O'Connor, E.J. Velazquez, and L.H. Gardner Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the Duke Cardiovascular Disease Databank) Am J Cardiol 90 2002 101 107
14. E.J. Velazquez, J.B. Williams, and E. Yow Long-term survival of patients with ischemic cardiomyopathy treated by coronary artery bypass grafting versus medical therapy Ann Thorac Surg 93 2012 523 530
15. M.L. Murphy, H.N. Hultgren, and K. Detre Treatment of chronic stable angina. A preliminary report of survival data of the randomized Veterans Administration cooperative study N Engl J Med 297 1977 621 627
16. Long-term results of prospective randomized study of coronary artery bypass surgery in stable angina pectoris Lancet 320 1982 1173 1180
17. Coronary Artery Surgery Study (CASS): a randomized trial of coronary artery bypass surgery. Survival data Circulation 68 1983 939 950
18. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group N Engl J Med 311 1984 1333 1339
19. E. Varnauskas Twelve-year follow-up of survival in the randomized European Coronary Surgery Study N Engl J Med 319 1988 332 337
20. E. Passamani, K.B. Davis, and M.J. Gillespie A randomized trial of coronary artery bypass surgery: survival of patients with a low ejection fraction N Engl J Med 312 1985 1665 1671
21. S. Yusuf, D. Zucker, and P. Peduzzi Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration Lancet 344 1994 563 570
22. W. Hueb, P.R. Soares, and B.J. Gersh The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results J Am Coll Cardiol 43 2004 1743 1751
23. W.E. Boden, R.A. O'Rourke, K.K. Teo COURAGE Trial Research Group Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 2007 1503 1516
24. BARI 2D Study Group, R.L. Frye, and P. August A randomized trial of therapies for type 2 diabetes and coronary artery disease N Engl J Med 360 2009 2503 2515
25. International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA). November 10, 2011. Updated April 3, 2014. Available at: http://clinicaltrials.gov/show/NCT01471522. Accessed November 24, 2014.
26. D.M. Bravata, K.M. McDonald, and A.L. Gienger Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Grafting for Coronary Artery Disease [Internet]. AHRQ Comparative Effectiveness Reviews, No. 9 2007 Agency for Healthcare Research and Quality Rockville, MD
27. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators N Engl J Med 335 1996 217 225
28. D.A. Morrison, G. Sethi, J. Sacks Angina With Extremely Serious Operative Mortality Evaluation (AWESOME) Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME) J Am Coll Cardiol 38 2001 143 149
29. P.B. Berger, J.L. Velianou, H. Aslanidou Vlachos for the BARI Investigators Survival following coronary angioplasty versus coronary artery bypass surgery in anatomic subsets in which coronary artery bypass surgery improves survival compared with medical therapy. Results from the Bypass Angioplasty Revascularization Investigation (BARI) J Am Coll Cardiol 38 2001 1440 1449
30. S.P. Sedlis, K.B. Ramanathan, D.A. Morrison for the Department of Veterans Affairs Cooperative Study #385, Angina With Extremely Serious Operative Mortality Evaluation (AWESOME) Investigators Outcome of percutaneous coronary intervention versus coronary bypass grafting for patients with low left ventricular ejection fractions, unstable angina pectoris, and risk factors for adverse outcomes with bypass (the AWESOME Randomized Trial and Registry) Am J Cardiol 94 2004 118 120
31. P.W. Serruys, M.C. Morice, A.P. Kappetein for the SYNTAX Investigators Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease N Engl J Med 360 2009 961 972
32. M.E. Farkouh, M. Domanski, L.A. Sleeper for the FREEDOM Trial Investigators Strategies for multivessel revascularization in patients with diabetes N Engl J Med 367 2012 2375 2384
33. E.J. Velazquez, K.L. Lee, C.M. O'Connor for the STICH Investigators The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial J Thorac Cardiovasc Surg 134 2007 1540 1547
34. E.J. Velazquez, K.L. Lee, M.A. Deja for the STICH Investigators Coronary-artery bypass surgery in patients with left ventricular dysfunction N Engl J Med 364 2011 1607 1616
35. T. Doenst, J.G. Cleland, and J.L. Rouleau Influence of crossover on mortality in a randomized study of revascularization in patients with systolic heart failure and coronary artery disease Circ Heart Fail 6 2013 443 450
36. D.B. Mark, J.D. Knight, and E.J. Velazquez Quality of life outcomes with coronary artery bypass graft surgery in ischemic left ventricular dysfunction: a randomized trial Ann Intern Med 161 2014 392 399
37. P. Carson, J. Wertheimer, A. Miller for the STICH Investigators The STICH trial (Surgical Treatment of Ischemic Heart Failure): mode-of-death results J Am Coll Cardiol HF 1 2013 400 408
38. From STICH to STICHES. STICH Surgical Treatment for Ischemic Heart Failure. Available at: https://www.stichtrial.org. Accessed November 24, 2014.
39. K.C. Allman, L.J. Shaw, and R. Hachamovitch Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis J Am Coll Cardiol 39 2002 1151 1158
40. P.G. Camici, S.K. Prasad, and O.E. Rimoldi Stunning, hibernation, and assessment of myocardial viability Circulation 117 2008 103 114
41. R.O. Bonow, G. Maurer, K.L. Lee for the STICH Trial Investigators Myocardial viability and survival in ischemic left ventricular dysfunction N Engl J Med 364 2011 1617 1625
42. J.A. Panza, T.A. Holly, and F.M. Asch Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction J Am Coll Cardiol 61 2013 1860 1870
43. A.M. Feldman, D.L. Mann, and L. She Prognostic significance of biomarkers in predicting outcome in patients with coronary artery disease and left ventricular dysfunction: results of the biomarker substudy of the Surgical Treatment for Ischemic Heart Failure trials Circ Heart Fail 6 2013 461 472
44. R.A.H. Stewart, D. Szalewska, and L. She Exercise capacity and mortality in patients with ischemic left ventricular dysfunction randomized to coronary artery bypass graft surgery or medical therapy: an analysis from the STICH Trial J Am Coll Cardiol HF 2 2014 335 343
45. J.A. Panza, E.J. Velazquez, and L. She Extent of coronary and myocardial disease and benefit from surgical revascularization in LV dysfunction J Am Coll Cardiol 64 2014 553 561
46. C.L. Athanasuleas, G.D. Buckberg, A.W.H. Stanley for the RESTORE Group Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation J Am Coll Cardiol 44 2004 1439 1445
47. A. Yamaguchi, H. Adachi, and K. Kawahito Left ventricular reconstruction benefits patients with dilated ischemic cardiomyopathy Ann Thorac Surg 79 2005 456 461
48. L. Menicanti, S. Castelvecchio, and M. Ranucci Surgical therapy for ischemic heart failure: single-center experience with surgical anterior ventricular restoration J Thorac Cardiovasc Surg 134 2007 433 441
49. R.H. Jones, E.J. Velazquez, R.E. Michler for the STICH Hypothesis 2 Investigators Coronary bypass surgery with or without surgical ventricular reconstruction N Engl J Med 360 2009 1705 1717
50. D.B. Mark, J.D. Knight, E.J. Velazquez for the Surgical Treatment for Ischemic Heart Failure (STICH) Trial Investigators Quality of life and economic outcomes with surgical ventricular reconstruction in ischemic heart failure: results from the Surgical Treatment for Ischemic Heart Failure trial Am Heart J 157 2009 837 844 e1-3
51. A.L.W. Shroyer, J.F. Collins, and F.L. Grover Evaluating clinical applicability: the STICH trial's findings J Am Coll Cardiol 56 2010 508 509
52. G.D. Buckberg, C.L. Athanasuleas, and A.S. Wechsler The STICH trial unravelled Eur J Heart Fail 12 2010 1024 1027
53. R.E. Michler, J.L. Rouleau, H.R. Al-Khalidi for the STICH Trial Investigators Insights from the STICH trial: change in left ventricular size after coronary artery bypass graft surgery with and without surgical ventricular reconstruction J Thorac Cardiovasc Surg 146 2013 1139 1145.e6
54. J.K. Oh, E.J. Velazquez, L. Menicanti for the STICH Investigators Influence of baseline left ventricular function on the clinical outcome of surgical ventricular reconstruction in patients with ischaemic cardiomyopathy Eur Heart J 34 2013 39 47
55. T.A. Holly, R.O. Bonow, and J.M.O. Arnold Myocardial viability and impact of surgical ventricular reconstruction on outcomes of patients with severe left ventricular dysfunction undergoing coronary artery bypass surgery: results of the Surgical Treatment for Ischemic Heart Failure trial J Thorac Cardiovasc Surg 148 2014 2677 2684
56. R.A. Levine, and E. Schwammenthal Ischemic mitral regurgitation on the threshold of a solution: from paradoxes to unifying concepts Circulation 112 2005 745 758
57. G.A. Lamas, G.F. Mitchell, and G.C. Flaker Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and Ventricular Enlargement Investigators Circulation 96 1997 827 833
58. F. Grigioni, M. Enriquez-Sarano, and K.J. Zehr Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment Circulation 103 2001 1759 1764
59. F. Grigioni, D. Detaint, and J.F. Avierinos Contribution of ischemic mitral regurgitation to congestive heart failure after myocardial infarction J Am Coll Cardiol 45 2005 260 267
60. A. Rossi, F.L. Dini, and P. Faggiano Independent prognostic value of functional mitral regurgitation in patients with heart failure: a quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy Heart 97 2011 1675 1680
61. M.A. Deja, P.A. Grayburn, and B. Sun Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial Circulation 125 2012 2639 2648
62. R.O. Bonow The saga continues: does mitral valve repair improve survival in secondary mitral regurgitation? J Am Coll Cardiol Intv 7 2014 882 884
63. R.A. Nishimura, C.M. Otto, R.O. Bonow American College of Cardiology/American Heart Association Task Force on Practice Guidelines 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 63 2014 e57 e185
64. S. Capomolla, O. Febo, and M. Gnemmi β-Blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol Am Heart J 139 2000 596 608
65. M.G. St John Sutton, T. Plappert, W.T. Abraham for the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Study Group Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure Circulation 107 2003 1985 1990
66. A.H. Wu, K.D. Aaronson, and S.F. Bolling Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction J Am Coll Cardiol 45 2005 381 387
67. T. Mihaljevic, B.K. Lam, and J. Rajeswaran Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation J Am Coll Cardiol 49 2007 2191 2201
68. E.C. McGee, A.M. Gillinov, and E.H. Blackstone Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation J Thorac Cardiovasc Surg 128 2004 916 924
69. M.A. Acker, M.K. Parides, and L.P. Perrault Mitral-valve repair versus replacement for severe ischemic mitral regurgitation N Engl J Med 370 2014 23 32
70. P.K. Smith, J.D. Puskas, and D.D. Ascheim Surgical treatment of moderate ischemic mitral regurgitation N Engl J Med 371 2014 2178 2188
71. K. Fattouch, F. Guccione, and R. Sampognaro POINT: Efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation: a randomized trial J Thorac Cardiovasc Surg 138 2009 278 285
72. K.M. Chan, P.P. Punjabi, M. Flather for the RIME Investigators Coronary artery bypass surgery with or without mitral valve annuloplasty in moderate functional ischemic mitral regurgitation: final results of the Randomized Ischemic Mitral Evaluation (RIME) trial Circulation 126 2012 2502 2510
73. A. Auricchio, W. Schillinger, S. Meyer for the PERMIT-CARE Investigators Correction of mitral regurgitation in nonresponders to cardiac resynchronization therapy by MitraClip improves symptoms and promotes reverse remodeling J Am Coll Cardiol 58 2011 2183 2189
74. G. Nickenig, R. Estevez-Loureiro, O. Franzen for the Transcatheter Valve Treatment Sentinel Registry Investigators of the EURObservational Research Programme of the European Society of Cardiology Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011-2012 Pilot European Sentinel Registry J Am Coll Cardiol 64 2014 875 884
75. M.J. Swaans, A.L.M. Bakker, and A. Alipour Survival of transcatheter mitral valve repair compared with surgical and conservative treatment in high-surgical-risk patients J Am Coll Cardiol Intv 7 2014 875 881
76. COAPT Clinical Trial. June 20, 2012. Updated October 24, 2014. Available at: http://clinicaltrials.gov/show/NCT01626079. Accessed November 24, 2014.
77. A Randomized Study of the MitraClip Device in Heart Failure Patients With Clinically Significant Functional Mitral Regurgitation (RESHAPE-HF). January 27, 2013. Updated October 6, 2014. Available at: http://clinicaltrials.gov/show/NCT01772108. Accessed November 24, 2014.